ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
132.344,88
0,30%
S&P 500
5.667,56
0,08%
US Dollar vs BRL
5,7351
0,00%
Bitcoin
84.306,14
0,31%
Brent Oil
71,775
0,00%
As Melhores Corretoras Online
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. ReShape Lifesciences Inc (RSLS)

  7. ReShape Lifesciences Inc (RSLS) Notícias

RSLS

ReShape Lifesciences (RSLS)

ReShape Lifesciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:RSLS
DataHoraFonteTítuloCódigoCompanhia
20/03/202517:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
14/03/202517:35Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:RSLSReShape Lifesciences Inc
13/03/202516:26Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:RSLSReShape Lifesciences Inc
10/03/202509:31GlobeNewswire Inc.ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation TechnologyNASDAQ:RSLSReShape Lifesciences Inc
25/02/202510:31GlobeNewswire Inc.ReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band® 2.0 FLEXNASDAQ:RSLSReShape Lifesciences Inc
24/02/202517:02Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:RSLSReShape Lifesciences Inc
18/02/202512:46Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RSLSReShape Lifesciences Inc
18/02/202502:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RSLSReShape Lifesciences Inc
16/02/202501:17GlobeNewswire Inc.ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public OfferingNASDAQ:RSLSReShape Lifesciences Inc
14/02/202523:11Edgar (US Regulatory)Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]NASDAQ:RSLSReShape Lifesciences Inc
14/02/202517:58Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:RSLSReShape Lifesciences Inc
03/02/202510:31GlobeNewswire Inc.ReShape Lifesciences® Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation TechnologyNASDAQ:RSLSReShape Lifesciences Inc
21/01/202508:06Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:RSLSReShape Lifesciences Inc
13/01/202510:31GlobeNewswire Inc.ReShape Lifesciences® Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad MedisysNASDAQ:RSLSReShape Lifesciences Inc
07/01/202516:52Edgar (US Regulatory)Form SCHEDULE 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:RSLSReShape Lifesciences Inc
11/12/202410:29Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:RSLSReShape Lifesciences Inc
06/12/202408:16Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:RSLSReShape Lifesciences Inc
14/11/202418:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RSLSReShape Lifesciences Inc
14/11/202418:05GlobeNewswire Inc.ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
12/11/202418:05GlobeNewswire Inc.ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
12/11/202410:31GlobeNewswire Inc.ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEXNASDAQ:RSLSReShape Lifesciences Inc
11/11/202410:31GlobeNewswire Inc.ReShape Lifesciences® Receives NIH Supplementary Grant with the University of Southern California’s Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes for ReShape’s Proprietary Diabetes BNASDAQ:RSLSReShape Lifesciences Inc
01/10/202418:22Edgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNASDAQ:RSLSReShape Lifesciences Inc
26/09/202417:45Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:RSLSReShape Lifesciences Inc
19/09/202409:31GlobeNewswire Inc.ReShape Lifesciences Announces 1-for-58 Reverse Stock SplitNASDAQ:RSLSReShape Lifesciences Inc
14/08/202417:05GlobeNewswire Inc.ReShape Lifesciences® Reports Second Quarter Ended June 30, 2024 Financial Results and Provides Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
13/08/202409:31GlobeNewswire Inc.ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
09/07/202413:13GlobeNewswire Inc.Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND”NASDAQ:RSLSReShape Lifesciences Inc
09/07/202409:31GlobeNewswire Inc.ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad MedisysNASDAQ:RSLSReShape Lifesciences Inc
15/05/202417:05GlobeNewswire Inc.ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:RSLS

Seu Histórico Recente

NYSE
LEN
Lennar
ASX
SLH
Silk Logistics
LSE
KCOM
Kcom
BIT
NSCIT8297136
Goldman Sachs
LSE
ARCM
Arc Minerals
BIT
NSCIT1878833
EIB European Investment ...
TG
VIP
Virtus Investment Partners
EU
IDNRA
AMUNDI DNRA INAV
EU
ALHPI
Hopium
GATE
BASEUSDT
Base Protocol
GATE
IOENUSDT
Internet of Energy Network
AMEX
PSR
Invesco Active US Real E...
EU
SGBP3
EN GBNP010622P
BITV
ALPHAEUR
Alpha Venture DAO
BTRX
MRPHETH
LSE
VEIL
Vietnam Enterprise Inves...
Delayed Upgrade Clock
ADVFN Logo
Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios